World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
67
Citations
21767
World Ranking
2647
National Ranking
104

William Vermi publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where William Vermi sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 208 publications — 37th percentile

37% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

William Vermi D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where William Vermi sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 67 D-Index — 47th percentile

47% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

William Vermi is affiliated with the University of Brescia in Italy. Their research centers primarily on immunology and microbiology, with significant work also conducted in the fields of medicine and oncology.

Their published research spans several key topics including:

  • Immune cells in cancer
  • Immune cell function and interaction
  • Cancer immunotherapy and biomarkers
  • Immunotherapy and immune responses
  • T-cell and B-cell immunology
  • Immune response and inflammation
  • Neutrophil, myeloperoxidase and oxidative mechanisms

Frequent co-authors collaborating with William Vermi include:

  • Mattia Bugatti
  • Silvia Lonardi
  • Matilde Monti
  • Francesco Missale
  • Marco A. Cassatella

They have contributed multiple papers to publication venues such as:

  • Frontiers in Immunology
  • Cancers
  • Zenodo (CERN European Organization for Nuclear Research)
  • Nature Communications
  • Cancer Immunology Research

Examples of recent papers authored or co-authored by William Vermi include:

  • "TREM2 Modulation Remodels the Tumor Myeloid Landscape Enhancing Anti-PD-1 Immunotherapy," 2020, Cell
  • "Tissue-resident FOLR2+ macrophages associate with CD8+ T cell infiltration in human breast cancer," 2022, Cell
  • "Endogenous murine microbiota member Faecalibaculum rodentium and its human homologue protect from intestinal tumour growth," 2020, Nature Microbiology
  • "Tumor-Associated Macrophages in Osteosarcoma: From Mechanisms to Therapy," 2020, International Journal of Molecular Sciences
  • "Single-cell analyses of Crohn's disease tissues reveal intestinal intraepithelial T cells heterogeneity and altered subset distributions," 2021, Nature Communications

William Vermi's research contributions reflect a focus on understanding the cellular and molecular mechanisms underlying immune responses, particularly in cancer and inflammatory diseases. The work involves analysis of tumor microenvironments, immune cell heterogeneity, and the interactions between immune cells and cancer therapies.

Best Publications

  • Adaptive immunity maintains occult cancer in an equilibrium state

    Catherine M. Koebel;William Vermi;William Vermi;Jeremy B. Swann;Jeremy B. Swann;Nadeen Zerafa

  • A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity

    Marina Cella;Anja Fuchs;William Vermi;Fabio Facchetti

  • IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia

    Yaming Wang;Kristy J Szretter;William Vermi;William Vermi;Susan Gilfillan

  • Intraepithelial Type 1 Innate Lymphoid Cells Are a Unique Subset of IL-12- and IL-15-Responsive IFN-γ-Producing Cells

    Anja Fuchs;William Vermi;William Vermi;Jacob S. Lee;Silvia Lonardi

  • BDCA-2, a Novel Plasmacytoid Dendritic Cell–specific Type II C-type Lectin, Mediates Antigen Capture and Is a Potent Inhibitor of Interferon α/β Induction

    Andrzej Dzionek;Yoshiaki Sohma;Jun Nagafune;Marina Cella

  • TREM2 Modulation Remodels the Tumor Myeloid Landscape Enhancing Anti-PD-1 Immunotherapy

    Martina Molgora;Ekaterina Esaulova;William Vermi;Jinchao Hou

  • Tissue-resident FOLR2+ macrophages associate with CD8+ T cell infiltration in human breast cancer

    Unknown

  • Plasmacytoid dendritic cell ablation impacts early interferon responses and antiviral NK and CD8(+) T cell accrual.

    Melissa Swiecki;Susan Gilfillan;William Vermi;Yaming Wang

  • Cancer immunoediting by the innate immune system in the absence of adaptive immunity

    Timothy O’Sullivan;Robert Saddawi-Konefka;William Vermi;Catherine M. Koebel

  • Role of ChemR23 in directing the migration of myeloid and plasmacytoid dendritic cells to lymphoid organs and inflamed skin

    William Vermi;Elena Riboldi;Valerie Wittamer;Francesca Gentili

  • Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity

    Mirna Balsamo;Francesca Scordamaglia;Gabriella Pietra;Claudia Manzini

  • Recruitment of immature plasmacytoid dendritic cells (plasmacytoid monocytes) and myeloid dendritic cells in primary cutaneous melanomas.

    William Vermi;Raffaella Bonecchi;Fabio Facchetti;Denise Bianchi

  • Macrophage colony-stimulating factor induces the proliferation and survival of macrophages via a pathway involving DAP12 and beta-catenin.

    Karel Otero;Isaiah R Turnbull;Pietro Luigi Poliani;William Vermi

  • Mature CD10+ and immature CD10− neutrophils present in G-CSF–treated donors display opposite effects on T cells

    Olivia Marini;Sara Costa;Dalila Bevilacqua;Federica Calzetti

  • BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations.

    Marta Cigognetti;Silvia Lonardi;Simona Fisogni;Piera Balzarini

  • Early, transient depletion of plasmacytoid dendritic cells ameliorates autoimmunity in a lupus model

    Sarah L. Rowland;Jeffrey M. Riggs;Susan Gilfillan;Mattia Bugatti

  • A novel molecular interaction for the adhesion of follicular CD4 T cells to follicular DC.

    Kent S. Boles;William Vermi;Fabio Facchetti;Anja Fuchs

  • Natural Killer Cells Control Tumor Growth by Sensing a Growth Factor.

    Alexander D. Barrow;Melissa A. Edeling;Vladimir Trifonov;Jingqin Luo

  • Distinct and complementary functions of MDA5 and TLR3 in poly(I:C)-mediated activation of mouse NK cells

    Stephen McCartney;William Vermi;Susan Gilfillan;Marina Cella

  • Plasmacytoid dendritic cells prime IFN‐γ‐secreting melanoma‐specific CD8 lymphocytes and are found in primary melanoma lesions

    Mariolina Salio;Marina Cella;William Vermi;Fabio Facchetti

  • Abstract 526: Cancer immunoediting by the innate immune system in the absence of adaptive immunity

    Jack Bui;Timothy O'Sullivan;Robert Saddawi-Konefka;William Vermi

Frequent Co-Authors

Fabio Facchetti
Fabio Facchetti University of Brescia
Silvano Sozzani
Silvano Sozzani Sapienza University of Rome
Marco Colonna
Marco Colonna Washington University in St. Louis
Marco A. Cassatella
Marco A. Cassatella University of Verona
Raffaele Badolato
Raffaele Badolato University of Brescia
Marina Cella
Marina Cella Washington University in St. Louis
Alberto Mantovani
Alberto Mantovani Humanitas University
Robert D. Schreiber
Robert D. Schreiber Washington University in St. Louis
Susan Gilfillan
Susan Gilfillan Washington University in St. Louis
Luigi D. Notarangelo
Luigi D. Notarangelo National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to a variety of online degree programs that complement this field. For those interested in clinical applications, accelerated pathways like the accelerated FNP program provide an efficient route to becoming a Family Nurse Practitioner, blending advanced immunological knowledge with patient care.

Individuals without a nursing background can pursue online degrees tailored to their needs, such as the online ABSN programs for non nurses. These programs facilitate a swift transition into nursing, which is useful for those aiming to integrate immunology into healthcare practice.

For students looking for less competitive entry points, considering the easiest accelerated nursing programs can be a practical option. These programs balance quality education with accessibility, enabling quicker entry into the healthcare workforce.

Additionally, pursuing foundational credentials through accredited LPN programs easy to get into offers a solid start for those aiming to build a career in immunology-related nursing roles. These programs provide essential skills that support further specialization and career advancement.

Best Scientists Citing William Vermi

Trending Scientists

Recently Published Articles